T1	Disease	77 91	ER -positive ,
T2	Chemical	92 111	endocrine therapy -
T3	Disease	124 151	HER2 -negative metastases ,
T4	Pharmacodynamic_phenotype	199 231	sensitivity to 5-fluorouracil is
T5	Genomic_factor	244 284	deficiencies in chromatin remodeling and
T6	Genomic_variation	244 317	deficiencies in chromatin remodeling and homologous recombination genes .
R1	treats	Arg1:T1	Arg2:T3
R2	isAssociatedWith	Arg1:T1	Arg2:T4
R3	isAssociatedWith	Arg1:T1	Arg2:T5
R4	isAssociatedWith	Arg1:T1	Arg2:T6
R5	treats	Arg1:T2	Arg2:T1
R6	treats	Arg1:T2	Arg2:T3
R7	increases	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T2	Arg2:T6
R10	treats	Arg1:T3	Arg2:T1
R11	isAssociatedWith	Arg1:T3	Arg2:T2
R12	isAssociatedWith	Arg1:T3	Arg2:T4
R13	isAssociatedWith	Arg1:T3	Arg2:T5
R14	isAssociatedWith	Arg1:T3	Arg2:T6
R15	treats	Arg1:T4	Arg2:T1
R16	influences	Arg1:T4	Arg2:T2
R17	increases	Arg1:T4	Arg2:T3
R18	increases	Arg1:T4	Arg2:T5
R19	increases	Arg1:T4	Arg2:T6
R20	treats	Arg1:T5	Arg2:T1
R21	increases	Arg1:T5	Arg2:T2
R22	increases	Arg1:T5	Arg2:T3
R23	increases	Arg1:T5	Arg2:T4
R24	increases	Arg1:T5	Arg2:T6
R25	treats	Arg1:T6	Arg2:T1
R26	influences	Arg1:T6	Arg2:T2
R27	treats	Arg1:T6	Arg2:T3
R28	increases	Arg1:T6	Arg2:T4
R29	increases	Arg1:T6	Arg2:T5
